There are concerns around safety. Compounding is somewhat controversial because they produce versions of FDA-approved drugs that are not FDA-approved, and may use chemical formulations (such as semaglutide salts) that aren't FDA-approved. [1]
The problem isn't that compounding pharmacies provide cheap versions of the same drug, it's that the compounding process doesn't produce exactly the same drug, and hasn't undergone the same stringent quality controls as Wegovy etc.
Ideally, these drugs should be cheap. The compounding is only done because there's a loophole that provides a market opportunity. The correct solution would be to improve the regulations in a way that would let more manufacturers produce safe generics.
The problem isn't that compounding pharmacies provide cheap versions of the same drug, it's that the compounding process doesn't produce exactly the same drug, and hasn't undergone the same stringent quality controls as Wegovy etc.
Ideally, these drugs should be cheap. The compounding is only done because there's a loophole that provides a market opportunity. The correct solution would be to improve the regulations in a way that would let more manufacturers produce safe generics.
[1] https://www.goodrx.com/classes/glp-1-agonists/compounded-sem...